Articles

A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction

Malignant Hematology Division, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Immunology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Biostatistics Program, H. Lee H. Lee Moffitt Cancer Center, Tampa, FL, USA
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
UCLA Medical Center, Los Angeles, CA, USA
Biostatistics Program, H. Lee H. Lee Moffitt Cancer Center, Tampa, FL, USA
Ishikawa Prefectural Central Hospital, Kuratsukihigashi, Kanazawa, Japan
Malignant Hematology Division, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Malignant Hematology Division, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Immunology Program, H. Lee Moffitt Cancer Center, Tampa, FL, USA
Vol. 99 No. 7 (2014): July, 2014 https://doi.org/10.3324/haematol.2012.083345